Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
08/03/1999 | US5933578 Method and device for determining the color appearance of color overprints |
08/03/1999 | US5933226 Attachment for a concentration measuring apparatus and a concentration measuring system |
08/03/1999 | US5933015 Method and apparatus for measuring in-place soil density and moisture content |
08/03/1999 | US5932791 Method and apparatus for the continuous determination of gaseous oxidation products |
08/03/1999 | US5932779 Transgenic mouse with mutation in endogenous melanocortin-4-receptor gene; obesity, anorexia, and cachexia treatment |
08/03/1999 | US5932706 Antibodies specific for a haemostatic protein their use for isolating protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
08/03/1999 | US5932704 Antibodies for GM-CSF receptor and uses thereof |
08/03/1999 | US5932703 The present invention provides purified and isolated polynucleotide sequences encoding a novel human macrophage-derived c--c chemokine designated mdc, and polypeptide analogs thereof. |
08/03/1999 | US5932700 Efficient antitumor agent; diagnostic tool for detection of uterine tumors |
08/03/1999 | US5932699 Retinoid X receptor-interacting polypeptides |
08/03/1999 | US5932694 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
08/03/1999 | US5932602 Treatment of platelet derived growth factor related disorders such as cancers |
08/03/1999 | US5932549 Treating alzheimer*s disease, septic shock, acute myelogenous leukemia, stroke, and inflammatory bowel disease |
08/03/1999 | US5932537 Contacting a mammalian cell that is responsive to interleukin-1 with an intracellular interleukin-1 receptor antagonist (?icil-1ra?) not normally found in said cell. |
08/03/1999 | US5932536 Compositions for neutralization of lipopolysaccharides |
08/03/1999 | US5932483 Synthetic peptide and its uses |
08/03/1999 | US5932481 Method for measuring metaplastic changes of mucus secreting epithelial cells |
08/03/1999 | US5932480 Measurement method and kit for hemoglobin A1c |
08/03/1999 | US5932477 This novel enzyme is particularly useful for screening candidate compounds for their ability to serve as potential anti-depressant, antiasthmatic or anti-inflammatory agents. |
08/03/1999 | US5932476 Cloning of chicken anemia virus DNA |
08/03/1999 | US5932474 Target sequences for synthetic molecules |
08/03/1999 | US5932470 Ectoparasite saliva proteins and apparatus to collect such proteins |
08/03/1999 | US5932465 Phosphodiesterase 8A |
08/03/1999 | US5932447 Use of purified oligonucleotides encoding the ribosome-inactivating protein for the expression of a ribosome-inactivating protein (rip) and in the construction of fusion proteins is also considered part of the present |
08/03/1999 | US5932436 Simple, sensitive, fast and accurate method; placing adult, oviparous daphnia of single clone into test and control media, incubation to optimize exposure of offspring to compound, data analysis; pollution control |
08/03/1999 | US5932431 Incubating sample, solid phase coupled to antibody, labeled conjugate of steroid analogue; measuring amount of label in solution or on separated solid phase; use of slightly different steroid conjugate improves antibody performance |
08/03/1999 | US5932430 Immunoassay for H. pylori in fecal specimens |
08/03/1999 | US5932429 Methods of diagnosing clinical subtypes of crohn's disease |
08/03/1999 | US5932428 Method for preparing a sample in a scan capillary for immunofluorescent interrogation |
08/03/1999 | US5932427 In vitro assay system for identifying compositions useful for stimulating B cells |
08/03/1999 | US5932422 Determining whether transformed mammalian cell will respond to drug by measuring level of enzyme and comparing to level in normal cell, increased level of enzyme indicates resistance; diagnosing resistant tumor cells |
08/03/1999 | US5932421 Methods and cell lines for identification of regulators of integrin activation |
08/03/1999 | US5932418 Testing for cytological damage or apoptosis; exposing transparent embryos to aqueous chemical solutions, electromagnetic waves or radiation; fixing and staining embryos; optically analyzing for presence of label |
08/03/1999 | US5932415 Processes and agents for detecting listerias |
08/03/1999 | US5932412 Synthetic peptides in human papillomaviruses 1, 5, 6, 8, 11, 16, 18, 31, 33 and 56, useful in immunoassay for diagnostic purposes |
08/03/1999 | US5932410 Assay for the detection of proteases |
08/03/1999 | US5932296 Process for producing a surface coated with amino groups |
08/03/1999 | US5932226 Method and kit for determining the optimum dosage level of physiologically useful substances |
08/03/1999 | US5932219 Polypeptides |
08/03/1999 | US5932212 Crosslinked protein crystal formulations and their use as catalysts in organic solvents |
08/03/1999 | US5932177 Biochemical analysis; improved fluid flow |
08/03/1999 | US5932175 Sensor apparatus for use in measuring a parameter of a fluid sample |
08/03/1999 | US5932174 Device for chloride ion removal prior to chemical oxygen demand analysis |
08/03/1999 | US5932097 Microfabricated magnetic particles for applications to affinity binding |
08/03/1999 | US5932095 Multi-chambered supercritical fluid extraction cartridge |
08/03/1999 | US5931802 Extracorporeal blood circulator |
08/03/1999 | US5930870 Measuring fiber length at input and output of a fiber processing machine |
07/30/1999 | CA2246001A1 Novel compounds |
07/29/1999 | WO1999038015A1 A method for use in the detection of narcotics in closed containers, preferably freight containers, and a system for performing the method |
07/29/1999 | WO1999038014A1 Assessing risk for integrin antagonist/agonist mediated diseases |
07/29/1999 | WO1999038013A2 Method for simultaneous identification of proteins and bonding partners |
07/29/1999 | WO1999038012A1 Assay for detection of phosphate or carbohydrate groups on serine residues |
07/29/1999 | WO1999038011A1 Circulating insulin-like growth factor-i and prostate cancer risk |
07/29/1999 | WO1999038010A1 PAI-2 AND t-PA AS DIAGNOSTIC MARKERS OF PERIODONTAL DISEASE |
07/29/1999 | WO1999038009A1 Detection system using liposomes and signal modification |
07/29/1999 | WO1999038008A1 Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors |
07/29/1999 | WO1999038007A1 Sensor |
07/29/1999 | WO1999038001A1 Optical sensor and method of operation |
07/29/1999 | WO1999037992A1 Method for differentiation of nucleated red blood cells |
07/29/1999 | WO1999037989A1 Reservoir-slit rheometer for the viscosity measurement of fast-reacting polymers |
07/29/1999 | WO1999037987A1 Sampling bottle for chlorinated organic compounds |
07/29/1999 | WO1999037821A1 Methods and compositions to investigate infection by hepatitis b virus and agents to prevent and treat the infection |
07/29/1999 | WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor |
07/29/1999 | WO1999037816A1 Methods for identifying therapeutic targets |
07/29/1999 | WO1999037814A1 Microparticles with multiple fluorescent signals |
07/29/1999 | WO1999037811A1 Biomarkers and targets for diagnosis, prognosis and management of prostate disease |
07/29/1999 | WO1999037807A1 Method of isolation of rna-binding compounds |
07/29/1999 | WO1999037802A1 Methods to identify myelostimulants |
07/29/1999 | WO1999037800A1 Antimicrobial compounds |
07/29/1999 | WO1999037798A1 Methods for detecting false negative results in blood screening assays using a single aliquot elevated baseline as an internal assay control |
07/29/1999 | WO1999037797A1 Antigen-specific cells, methods of generating these cells and uses thereof |
07/29/1999 | WO1999037791A1 Multipurpose antibody derivatives |
07/29/1999 | WO1999037790A1 Human calcineurin b-like protein |
07/29/1999 | WO1999037788A2 Diagnosis and treatment of aur1 and/or aur2 related disorders |
07/29/1999 | WO1999037783A2 Live vaccine against brucellosis |
07/29/1999 | WO1999037780A1 Expression of the insl4 gene in human embryonic bone tissues and applications |
07/29/1999 | WO1999037771A1 A new human tumor-associated gene |
07/29/1999 | WO1999037766A2 A purified polynucleotide sequence containing a region encoding a mutated zap-70 protein or a fragment thereof |
07/29/1999 | WO1999037763A2 Novel nucleic acid molecules correlated with the rhesus weak d phenotype |
07/29/1999 | WO1999037762A1 Trek-1 like two pore potassium channel |
07/29/1999 | WO1999037717A1 Asymmetric cyanine dye quenchers |
07/29/1999 | WO1999037679A1 Ligand receptors and uses therefor |
07/29/1999 | WO1999037672A1 Method of screening for neuropharmaceuticals using the drosophila gene volado and its mutants |
07/29/1999 | WO1999037409A1 Functionalized porous silicon surfaces |
07/29/1999 | WO1999037330A1 Method for determining gene essentiality in a pathogen |
07/29/1999 | WO1999037313A1 Immune effector cell hybrids |
07/29/1999 | WO1999037299A1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer |
07/29/1999 | WO1999037203A2 Apparatus and methods for improving signal resolution in optical spectroscopy |
07/29/1999 | WO1999037147A1 Selection of mature sperm by surface membrane determinants |
07/29/1999 | WO1999028471A3 ANTIBODIES, INCLUDING Fv MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE |
07/29/1999 | WO1999028047A3 Artificial surface with predetermined affinity |
07/29/1999 | WO1999025347A3 Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction |
07/29/1999 | WO1999021580A9 Reagents and immunoassay for the detection and quantitative determination of mycothiol and precursors thereof |
07/29/1999 | WO1999019506A3 Method for identifying binding ligands to receptors |
07/29/1999 | WO1999006831A9 Breast cancer resistance genes, methods for their detection and uses thereof |
07/29/1999 | DE4244975C2 Automatic blood sample examination appts. |
07/29/1999 | DE19802174A1 Identifying T-cell stimulating fragments of antigenic proteins or peptides, useful as immunostimulants for vaccination or desensitization |
07/29/1999 | DE19758017A1 Verfahren zum Nachweis von Borna-Disease-Virus (BDV)-Infektionen über den Nachweis zirkulierender Immunkomplexe und hierfür verwendbarer diagnostischer Kit A method for detecting Borna disease virus (BDV) infections through the detection of circulating immune complexes and therefor useful diagnostic kit |
07/29/1999 | DE19749091C1 New Antibodies against vasodilator-stimulated phosphoprotein |
07/29/1999 | CA2707152A1 Biomarkers and targets for diagnosis, prognosis and management of prostate disease |